Program to Expand State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening to Include Severe Combined Immune Deficiency (SCID) (U01)

The summary for the Program to Expand State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening to Include Severe Combined Immune Deficiency (SCID) (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Program to Expand State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening to Include Severe Combined Immune Deficiency (SCID) (U01)
	CFDA Number:	93.065
	CFDA Description:	Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure
	Federal Agency Name:	Centers for Disease Control and Prevention
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-EH-08-002
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Mar 10, 2008
	Creation Date:	Mar 10, 2008
	Original Closing Date for Applications:	May 09, 2008 Letter of Intent Deadline: April 9, 2008
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Jun 08, 2008
	Expected Number of Awards:	2
	Estimated Total Program Funding:	$1,000,000
	Federal Grant Award Ceiling:	$500,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligibility as primary applicants for this cooperative agreement is limited to U.S. State or Territorial Public Health Laboratories with existing Newborn Bloodspot Screening programs or consortia comprised thereof.
Grant Description: CDCs Procurement and Grants Office has published a funding opportunity announcement entitled, "Program to Expand State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening to Include Severe Combined Immune Deficiency (SCID) (U01)." Approximately $1,000,000 will be available in fiscal year 2008 to fund 2 awards. The purpose of the program is to conduct research to develop and evaluate newborn bloodspot screening tests for forms of Severe Combined Immune Deficiency Disease (SCID). Newborn bloodspot screening (NBS) is a vital public health program that tests babies for congenital disorders which are not apparent at birth. For complete program details, please see the full announcement on the CDC website at http://www.cdc.gov/od/pgo/funding/EH08-002.htm. The estimated funding date is August 31, 2008.
Link to Full Grant Announcement: Program to Expand State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening to Include Severe Combined Immune Deficiency (SCID) (U01)
http://www.cdc.gov/od/pgo/funding/EH08-002.htm
Grant Announcement Contact: PGOTIMS
Phone 770/488-2700 pgotim@cdc.gov Technical Information Management Section
Similar Government Grants: • Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for ...; • APHL-CDC PARTNERSHIP FOR QUALITY LABORATORY MEDICINE; • Association of Public Health Laboratories (APHL)